19 May 2013
Keywords: Mitsubishi Tanabe, Bipha, Nipro, Joint venture dissolved, Blood products
Article | 03 September 2012
Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580 shares) held by fellow Japan based Nipro ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.